Scholar IQ
Help
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

CAR-T cell therapy research

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on Chimeric Antigen Receptor (CAR) T cell therapy, a form of immunotherapy that uses genetically engineered T cells to target and destroy cancer cells. The papers cover various aspects of CAR T cell therapy, including its application in treating leukemia, lymphoma, and solid tumors, the management of cytokine release syndrome associated with this therapy, and the long-term efficacy and safety of CAR T cell treatment.

84,729
Works
1,409,291
Citations
How has CAR-T cell therapy research's publication output changed over time?
ScholarIQpublication output · 2016–2018

Output grew0% over the shown period — from 1 works in 2016 to 1 in 2018.

1
1
20162018
Who are the most-cited researchers behind CAR-T cell therapy research?
ScholarIQtop researchers by citations
1
Dirk Schadendorf · Melanoma and MAPK Pathways
2,390 works226,911 citations
2
Jedd D. Wolchok · Cancer Immunotherapy and Biomarkers
1,445 works209,224 citations
3
Georgina V. Long · Cancer Immunotherapy and Biomarkers
1,822 works178,195 citations
4
Drew M. Pardoll · Cancer Immunotherapy and Biomarkers
895 works168,977 citations
5
Antoni Ribas · Cancer Immunotherapy and Biomarkers
1,722 works165,576 citations
What are the most-cited papers on CAR-T cell therapy research?
ScholarIQmost cited works
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh, Benjamin Izar, Sanjay M. Prakadan, Marc H. Wadsworth, Daniel J. Treacy, John J. Trombetta, Asaf Rotem, Christopher Rodman, Christine G. Lian, Gëorge F. Murphy, Mohammad Fallahi‐Sichani, Ken Dutton‐Regester, Jia‐Ren Lin, Ofir Cohen, Parin Shah, Diana Lu, Alex S. Genshaft, Travis K. Hughes, Carly G.K. Ziegler, Samuel W. Kazer, Aleth Gaillard, Kellie E. Kolb, Alexandra–Chloé Villani, Cory M. Johannessen, Aleksandr Andreev, Eliezer M. Van Allen, Monica M. Bertagnolli, Peter K. Sorger, Ryan J. Sullivan, Keith T. Flaherty, Dennie T. Frederick, Judit Jané‐Valbuena, Charles H. Yoon, Orit Rozenblatt–Rosen, Alex K. Shalek, Aviv Regev, Levi A. Garraway
Science. 20165,337 CitationsOPEN ACCESS
Chimeric Antigen Receptor Therapy
Carl H. June, Michel Sadelain
New England Journal of Medicine. 20182,312 CitationsOPEN ACCESS
Where is CAR-T cell therapy research research published, and who funds it?
ScholarIQvenues & funding sources
TOP FUNDERS
National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock
How much of the research on CAR-T cell therapy research is open access?
ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
50%
Hybrid
0%
Bronze
50%
Closed
0%
Who collaborates most closely around CAR-T cell therapy research?
ScholarIQco-authorship network
United States
100%
Related on ScholarIQ
National Cancer Institute
Institution
University of Pennsylvania
Institution
Memorial Sloan Kettering Cancer Center
Institution
Dana-Farber Cancer Institute
Institution
Washington University in St. Louis
Institution
The University of Texas MD Anderson Cancer Center
Institution
470M+ articles · free account